Complaint
PRODUCT DESCRIPTION
MDM patented technology (MBMT + DMCT + MDAP)
MBMT (Micro Bead Monophasic Technology)
Enable the world's largest Viscoelasticity by microbeading of the HA (Hyaluronic Acid) and maintaining Monophasic properties.
DMCT (Divinyl sulfone Multi-Crosslink Technology)
Multi-crosslinking of HA (Hyaluronic Acid) with DVS crosslinking agent. A technology to implement complete crosslinking.
MDAP (Multiple Degree Amphiphilic Purification)
Technology that improves safety and produces the highest purity products by refining crosslinked microbeads in multiple times.
Long lasting
Molding ability : Soft
Final type : Monophasic (Gel Only)
Appearance : Transparent, colorless gel
Certification : KGMP / ISO13485 / MDSAP
Product registration : Russia, Dominica Republic, Malaysia, Singapore, Vietnam, Republic of Azerbaijan, Ukraine, Costa Rica, Columbia and etc.
PRODUCT GRADE
• Quality : ★★★★★
• Visco-elasticity : ★★☆☆☆
• Moldability : ★★☆☆☆
• Cohesiveness : ★★☆☆☆
PRODUCT SPECIFICATION
- Contents : Cross-linked HA
- Volume : 2mL / syringe
- Concentration : 20mg / mL
- Injection Force(Viscosity) : 6.7 ~ 7.4 N
- Recommended area : Forehead
- Needle : 31G 13mm
34G 12mm Multi-Needle
Hyaldew Filler
The new technology and patented bead design gathers many particles from the existing cross- linking technology and forms them into one micro bead.
Also, the cohesiveness and viscosity have been strengthened from the high cross-linking rate of HA. Thanks to the new technology of 'Bead Cross-Linking', long lasting volumizing effect is possible, overcoming the limitations of HA fillers!
